CSA Research brief on ModelFront for a clinical research organization
28 April 2026
CSA Research published a brief on how a clinical research organization uses ModelFront to scale translation for regulated clinical content.
- Approximately 60 million new words checked and processed annually
- ModelFront applied to both translation and review steps
- On-premise, auditable, integrated into existing workflows
ModelFront Brings Quality Estimation to Regulated Clinical Content at Scale
Alison Toon, 28 April 2026Enterprises in regulated industries face pressure to scale localization while maintaining strict quality, compliance, and risk controls, raising questions about how far artificial intelligence can safely reduce – or help – human effort.
This briefing shows how ModelFront applies automated quality estimation to minimize the first post-editing stage, targeting the highest-cost step while maintaining the stringent required quality thresholds and auditability.
The results indicate a shift toward confidence-driven workflows where artificial intelligence directs human effort rather than replaces it, especially in high-risk environments.
This matters because it enables cost and time reduction without compromising regulatory requirements. Enterprise buyers in all industries can use this report to evaluate AI adoption strategies and optimize localization workflows.
Read the full brief on CSA Research → (opens in a new tab)